Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42

2005 ◽  
Vol 26 (6) ◽  
pp. 785-788 ◽  
Author(s):  
Marco Duering ◽  
Marcus O.W. Grimm ◽  
Heike S. Grimm ◽  
Johannes Schröder ◽  
Tobias Hartmann
1995 ◽  
Vol 183 (1-2) ◽  
pp. 1-3 ◽  
Author(s):  
Benedetta Nacmias ◽  
Stefania Latorraca ◽  
Patrizia Piersanti ◽  
Paolo Forleo ◽  
Silvia Piacentini ◽  
...  

2003 ◽  
Vol 15 (4) ◽  
pp. 337-349 ◽  
Author(s):  
Silvia Mejía ◽  
Margarita Giraldo ◽  
David Pineda ◽  
Alfredo Ardila ◽  
Francisco Lopera

Objective: The purpose of this research was to identify environmental and personal factors that could be related to the variability in the age of onset of familial Alzheimer's disease (FAD) (36–62 years). Methods: A sample was taken of 49 subjects with FAD and with the mutation E280A in the presenilin-1 gene on chromosome 14; the sample was divided into two subgroups: 27 individuals with age of onset of the disease between 36 and 46 years (early onset) and 22 individuals whose disease began between 47 and 62 years (late onset). Information on environmental and personal factors was collected by means of a questionnaire answered by the patients if their clinical condition allowed it, or by their relatives; such information was organized in a categorical way. Comparisons between the two groups for each categorical variable were done by means of the chi-square test. Noncollinear variables that showed statistical significance were included as independent variables in a logistic regression analysis to predict their association with early onset of the disease. Results: Only 5 of the 140 studied variables were different between the two groups in univariate analysis: education, surgical history, type of stressful event, depression, and affective losses. The logistic regression model was constituted by education, depression, and affective losses. High-level education had approximately 15 times more probability of association with an early onset of the disease; both the history of affective losses and depressive symptoms had 4 times more probability of a similar association. Conclusions: The association of high-level education and early onset of the disease could be related to an earlier detection of symptoms, in turn determined by greater intellectual and environmental demands. The occurrence of depression and affective losses has been considered a prodromic manifestation of the disease. Our findings are evidence of high clinical heterogeneity even in a genetically homogeneous group.


2019 ◽  
Vol 703 ◽  
pp. 111-118 ◽  
Author(s):  
Miguel Mendivil-Perez ◽  
Carlos Velez-Pardo ◽  
Kenneth S. Kosik ◽  
Francisco Lopera ◽  
Marlene Jimenez-Del-Rio

1995 ◽  
Vol 38 (4) ◽  
pp. 678-680 ◽  
Author(s):  
Ephrat Levy-Lahad ◽  
Amnon Lahad ◽  
Ellen M. Wijsman ◽  
Thomas D. Bird ◽  
Gerard D. Schellenberg

Author(s):  
Mireia Seuma ◽  
Andre Faure ◽  
Marta Badia ◽  
Ben Lehner ◽  
Benedetta Bolognesi

AbstractAmyloid fibrils are associated with many human diseases but how mutations alter the propensity of proteins to form fibrils has not been comprehensively investigated and is not well understood. Alzheimer’s Disease (AD) is the most common form of dementia with amyloid plaques of the amyloid beta (Aß) peptide a pathological hallmark of the disease. Mutations in Aß also cause familial forms of AD (fAD). Here we use deep mutational scanning to quantify the effects of >14,000 mutations on the aggregation of Aß. The resulting genetic landscape reveals fundamental mechanistic insights into fibril nucleation, including the importance of charge and gatekeeper residues in the disordered region outside of the amyloid core in preventing nucleation. Strikingly, unlike computational predictors and previous measurements, the in vivo nucleation scores accurately identify all known dominant fAD mutations, validating this simple cell-based assay as highly relevant to the human genetic disease and suggesting accelerated fibril nucleation is the ultimate cause of fAD. Our results provide the first comprehensive map of how mutations alter the formation of any amyloid fibril and a validated resource for the interpretation of genetic variation in Aß.HighlightsFirst comprehensive map of how mutations alter the propensity of a protein to form amyloid fibrils.Charge and gatekeeper residues in the disordered N-terminus of amyloid beta prevent fibril nucleation.Rates of nucleation in a cell-based assay accurately identify the mutations that cause dominant familial Alzheimer’s disease.The combination of deep mutational scanning and human genetics provides a general strategy to quantify the disease-relevance of in vitro and in vivo assays.


Sign in / Sign up

Export Citation Format

Share Document